First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure
Aoife Molloy1, Satheesh Nair, Fiona J Cooke
1Department of Infectious Diseases, Addenbrooke’s Hospital, Cambridge, United Kingdom. aoifemolloy@gmail.com
Abstract:
The prevalence of Salmonella enterica serotype Paratyphi A infection is increasing, and multidrug resistance is a well-recognized problem. Resistance to fluoroquinolones is common and leads to more frequent use of newer agents like azithromycin. We report the first case of azithromycin resistance and treatment failure in a patient with S. Paratyphi A infection.
Insights
Salmonella Paratyphi A infections are rising, with increasing drug resistance. This study details the first reported case of azithromycin resistance and treatment failure in Salmonella Paratyphi A, highlighting a critical challenge in infectious disease management.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Salmonella enterica serotype Paratyphi A (S. Paratyphi A) infections are increasingly prevalent globally.
- Multidrug resistance in S. Paratyphi A, particularly to fluoroquinolones, is a significant clinical concern.
- This resistance necessitates the use of alternative antibiotics such as azithromycin.
Observation:
- A case of Salmonella Paratyphi A infection is presented.
- The patient experienced treatment failure despite azithromycin administration.
Findings:
- This report documents the first instance of azithromycin resistance in S. Paratyphi A.
- The observed resistance led to a failure in treating the patient's infection.
Implications:
- The emergence of azithromycin resistance in S. Paratyphi A poses a serious threat to public health.
- This finding underscores the urgent need for continuous surveillance of antimicrobial resistance patterns.
- Development of novel therapeutic strategies is crucial to combat resistant S. Paratyphi A infections.
Related Concept Videos
Rocky Mountain Spotted Fever
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

